Also, the anti-cancer effects of FMBP were mainly achieved through the accumulation of more ROS in colon cancer cells than normal cells, attributed to the down-regulation of NF-E2-related factor 2 (Nrf2) expression, and the reduction of catalase activities and glutathione contents [45]. Here, NFE2L2 is linked to malignant colon neoplasm.